Lipid Mediators in the Pathogenesis and Resolution of Sepsis and ARDS

Chapter
Part of the Annual Update in Intensive Care and Emergency Medicine book series (AUICEM)

References

  1. 1.
    Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92–101CrossRefGoogle Scholar
  2. 2.
    Basil MC, Levy BD (2016) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 16:51–67CrossRefGoogle Scholar
  3. 3.
    Dalli J, Colas RA, Quintana C et al (2017) Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes. Crit Care Med 45:58–68CrossRefGoogle Scholar
  4. 4.
    Cajka T, Fiehn O (2014) Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Anal Chem 61:192–206CrossRefGoogle Scholar
  5. 5.
    Grumbach Y, Quynh NVT, Chiron R, Urbach V (2009) LXA4 stimulates ZO-1 expression and transepithelial resistance in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 296:L101–L108CrossRefGoogle Scholar
  6. 6.
    Meng F, Mambetsariev I, Tian Y et al (2015) Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation. Am J Respir Cell Mol Biol 52:152–161CrossRefGoogle Scholar
  7. 7.
    Wang Q, Lian QQ, Li B et al (2013) Lipoxin A4 activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluld clearance. Am J Respir Cell Mol Biol 48:610–618CrossRefGoogle Scholar
  8. 8.
    Tam VC, Quehenberger O, Oshansky C et al (2013) Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154:213–227CrossRefGoogle Scholar
  9. 9.
    Morita M, Kuba K, Ichikawa A et al (2013) The lipid mediator protectin D1 inhibits influenza viral replication and improves severe influenza. Cell 153:112–125CrossRefGoogle Scholar
  10. 10.
    Sordi R, Menez-de-Lima O Jr, Horewicz V et al (2013) Dual role of lipoxin A4 in pneumosepsis pathogenesis. Int Immunopharm 17:283–292CrossRefGoogle Scholar
  11. 11.
    Seki H, Fukunaga K, Artia M et al (2009) The anti-inflammatory and proresolving mediator resolving E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 184:836–843CrossRefGoogle Scholar
  12. 12.
    Walker J, Dichter E, Lacorte G et al (2011) Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36:410–416CrossRefGoogle Scholar
  13. 13.
    Tobin D, Roca JF, Oh SF et al (2012) Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148:434–446CrossRefGoogle Scholar
  14. 14.
    Fang X, Abbott J, Cheng L, Lee JW, Levy BD, Matthay MA (2015) Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. J Immunol 195:875–881CrossRefGoogle Scholar
  15. 15.
    Matthay M, Eschenbacher WL, Goetzl EJ (1984) Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J Clin Immunol 4:479–483CrossRefGoogle Scholar
  16. 16.
    Snapper JR, Hutchinson AA, Ogletree ML, Brigham KL (1983) Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 72:63–76CrossRefGoogle Scholar
  17. 17.
    Martin TR, Pistoresse BP, Chi EY, Goodman RB, Matthay MA (1989) Effects of leukotriene B4 in the human lung. J Clin Invest 84:1609–1619CrossRefGoogle Scholar
  18. 18.
    Ratnoff WD, Matthay MA, Wong MY et al (1988) Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome. J Clin Immunol 8:250–258CrossRefGoogle Scholar
  19. 19.
    Hamilton B, Gronert K, Gotts JE, Calfee CS, Ware LB, Matthay MA (2017) Integrated analysis method of soluble lipid mediators in alveolar fluid discriminates ARDS from hydrostatic pulmonary edema. Am J Respir Crit Care Med 195:A4356 (abst)Google Scholar
  20. 20.
    von Moltke J, Trinidad NJ, Moayeri M et al (2012) Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490:107–111CrossRefGoogle Scholar
  21. 21.
    Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trials. Lancet Respir Med 2:611–620CrossRefGoogle Scholar
  22. 22.
    Famous K, Delucchi K, Ware LB et al (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of CaliforniaSan FranciscoUSA
  2. 2.Department of Medicine and Division of Allergy, Critical Care and Pulmonary MedicineVanderbilt UniversityNashvilleUSA
  3. 3.Cardiovascular Research InstituteUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations